Paul Conroy

Title: Paul Conroy: Innovator in T Cell Receptor Technology

Introduction

Paul Conroy is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of immunology, particularly in the development of T cell receptor (TCR) technologies. His work has implications for therapeutic applications in cancer treatment and other diseases.

Latest Patents

Paul Conroy holds a patent for T cell receptors and fusion proteins thereof. The patent describes T cell receptor fusion proteins that bind to a specific HLA-A*02 complex. These proteins are covalently linked to a T cell engaging domain and an antibody Fc domain. The patent also encompasses related polynucleotides, vectors, kits, host cells, and pharmaceutical compositions.

Career Highlights

Conroy is associated with Immunocore Limited, a company that focuses on developing innovative therapies based on T cell receptor technology. His work at Immunocore has positioned him as a key player in advancing the understanding and application of TCRs in medical science.

Collaborations

Throughout his career, Paul Conroy has collaborated with esteemed colleagues such as Stephen Hearty and Lok Hang Mak. These collaborations have further enriched his research and contributed to the success of his projects.

Conclusion

Paul Conroy's contributions to T cell receptor technology highlight his role as an innovator in the field of immunology. His patent and work at Immunocore Limited demonstrate his commitment to advancing therapeutic solutions.